The interaction between myelinating Schwann cells and the axons they ensheath is mediated by cell adhesion molecules of the
Introduction
Peripheral nerve myelin is a specialized multilamellar membrane produced by Schwann cells that spirals around the axon. The myelin units (internodes) are separated from each other by a nonmyelinated gap known as the node of Ranvier (Jessen and Mirsky, 2005) . This configuration allows fast saltatory propagation of action potentials along myelinated axons. The myelin unit comprises areas of compact and noncompact myelin. The latter are located at the paranodal loops, Schmidt-Lanterman incisures, and the inner and outer mesaxons (Scherer and Arroyo, 2002) . Noncompact myelin contains tight, gap, and adherens junctions Spiegel and Peles, 2002) . The complex architecture of the myelin unit depends on various cell adhesion molecules (CAMs) that are localized to specific membrane contact sites present within the unit (Fannon et al., 1995; Altevogt et al., 2002; Miyamoto et al., 2005; Scheiermann et al., 2007; Kikuchi et al., 2010) , between the external layer and the surrounding basal lamina (Court et al., 2006) , or between the internal Schwann cell membrane and the axon (Pedraza et al., 1990; Einheber et al., 1997; Poliak et al., 1999; Tait et al., 2000; Maurel et al., 2007; . At the axon-glial interface, CAMs are thought to regulate cell recognition and functional organization of the axolemma into distinct domains, which are essential for saltatory conduction Susuki and Rasband, 2008) .
Cell adhesion molecule 4 (Cadm4; also known as SynCAM4 or Necl4) mediates Schwann cell-axon interaction (Maurel et al., 2007; . Cadm4 belongs to a distinct family of CAMs (Cadm1-Cadm4), which mediate specific cell-cell contact through homophilic and heterophilic interactions Takai et al., 2008) . In the peripheral nervous system (PNS), Cadm proteins are differentially expressed in Schwann cells and axons; Cadm1, Cadm2, and Cadm3 are found in axons, whereas Cadm4 and Cadm2 are present in myelinating Schwann cells (Maurel et al., 2007; . Axon-glia interaction is primarily mediated by binding of glial Cadm4 to axonal Cadm3 and Cadm2 (Maurel et al., 2007; . Disruption of this interaction by the addition of a soluble extracellular domain of Cadm4 to myelinating cultures markedly reduced the number of myelin segments . Similarly, expression of a dominant mutant form of Cadm4 in Schwann cells , or knockdown of Cadm4 by shRNA (Maurel et al., 2007) , led to reduced myelination, further suggesting that Cadms play a critical role in myelination. Genetic inactivation of Cadm3 in mice delays myelination in the CNS but does not affect the PNS (Park et al., 2008) . In the present study, we set to examine the role of Cadm proteins in myelination in vivo by generating mice that lack each member of this family. Our results suggest that Cadm4 plays an essential role not only in mediating Schwann cell-axon contact, but also in myelin membrane growth in the PNS.
Materials and Methods
Generation of mutant mice. Cadm2 (SynCAM2/Necl3), Cadm3 (Syn-CAM3/Necl1), and Cadm4 (SynCAM4/Necl4) mutant mice were generated by a standard gene targeting approach, using targeting vectors containing a Neomycin (Neo) resistance gene flanked by two FRT sites and two loxP sites that flank exon1 in Cadm2 and Cadm3, or exons 2-6 in Cadm4. Chimeric mice were bred with SvEv129 mice. Targeted mice were crossed with FLP deleter mice (Farley et al., 2000) to remove the Neo cassette, leaving the targeted Cadm exons floxed by a pair of loxP sites. Deletion of the floxed region was achieved by further crossing to either PGK-Cre (Lallemand et al., 1998) or Dhh-Cre (Jaegle et al., 2003) mice. Southern blot analysis was done as described previously . Genotyping was done by PCR of genomic DNA using the following primer: Cadm1 WT allele, GATGTGTGCTGACTTAGGAACG GTC and GAGTGATTAACAACGTGCAGGCAAT; targeted, GATGTG TGCTGACTTAGGAACGGTCandTGCGAGGCCAGAGGCCACTTGT Figure 1 . Absence of Cadm4, or transgenic expression of a Cadm4 mutant lacking its cytoplasmic domain, results in motor abnormalities. A, Schematic representation of the targeting vector (construct), genomic Cadm4, floxed, and mutant loci. Exons (blue boxes), loxP sites (red triangles), FRT sites (blue triangles), and primers used for genotyping (P1-P3) are indicated. B, Southern blot analysis of genomic DNA of WT (ϩ/ϩ), heterozygous (Ϫ/ϩ), or null (Ϫ/Ϫ) mice using the 3PPb probe. Molecular mass markers given in kb. C, PCR analysis of genomic tail DNA of the indicated genotypes detecting the WT and targeted Cadm4 alleles, and the Cre gene. D, RT-PCR analysis of sciatic nerve mRNA using primer pairs present in exons 3-6 (Ex3-6) and 7-9 (Ex7-9) revealed the absence of a complete Cadm4 transcript in homozygous mice. Primers for actin were used as controls. C, D, Size markers given in bp. E, Western blot analysis of sciatic nerves of the indicated genotypes using antibodies that recognize the cytoplasmic (CYT) or extracellular (ECD) domains of Cadm4, or tubulin as control. No signal is detected in homozygous mice. Molecular mass markers indicated in kDa. F, Cadm4 is undetectable in sciatic nerves of Cadm4 Ϫ/Ϫ -null. Cross sections (top) or teased sciatic nerves (bottom) isolated from the indicated genotypes at 2 months of age, immunolabeled using antibodies to Cadm4 and neurofilament (NFH). Insets, Higher magnification of the boxed area. Arrowhead indicates the concentration of Cadm4 in Schmidt-Lanterman incisures. Scale bars, 10 m. G, Transgenic expression of a deletion variant of Cadm4 in Schwann cells. Western blot analysis of sciatic nerves isolated from WT or transgenic mice expressing a myc-tagged Cadm4 lacking its cytoplasmic domain under the control of an MBP promoter Tg(mbp-Cadm4dCT ). The cytoplasmic Cadm4 antibody (Cadm4-CYT) only recognizes the endogenous protein, whereas the extracellular antibody (Cadm4-ECD) detects both endogenous and transgenic proteins. Tubulin was used as a loading control. There is moderate reduction in endogenous Cadm4 in the transgene. Molecular mass markers indicated in kDa. H, I, Immunolabeling of teased sciatic nerves isolated from Tg(mbp-Cadm4dCT ) using antibodies to myc-tag (Myc), neurofilament (NFH), and Cadm4 (H ), or myc-tag and Cadm4 (I ). Merged images are shown at the bottom. H, Two myelinated axons that either lack (a) or express (b) the transgene. The presence of the transgene changes the distribution of the endogenous Cadm4 (H, arrowheads). I, Although endogenous Cadm4 is only weakly detected in myelin units overexpressing the transgene, it is normally present in myelinating Schwann cells lacking it (arrowhead). Scale bars, 10 m. J, Cadm4 Ϫ/ Ϫ and Tg(mbp-Cadm4dCT ) mice exhibit abnormal clasping of their hindlimbs when suspended by their tail. Tg(mbp-Cadm4dCT ) animals also developed hindlimb paralysis (top). K, Analysis of motor performance by rotarod. Adult Cadm4 Ϫ/ Ϫ (Cadm4 ) and Tg(mbp-Cadm4dCT ) mice exhibit a shorter latency to fall compared with their littermate controls. Error bars indicate SD of n Ͼ 8 mice per genotype. **p Ͻ 0.001. L, Compound action potentials recorded from adult mice show a reduction in nerve conduction velocity in both mutants. Error bars indicate SD of n Ͼ 6 mice per genotype. **p Ͻ 0.001.
GTAGC; Cadm2 WT allele, AGGCACAAGT TGCCAGCCA and ATTCCACCCCGTATTT CCA; targeted, AGGCACAAGTTGCCAGCCA and CAAGTTAGCACGTGGCCACC; Cadm3 WT allele, GCCCTGACTGAAACAGCGAC and CAGGGAGCCTGTTGGCTTTG; targeted,GCCCTGACTGAAACAGCGACandCT TTGCTCCACACCCGAGTG; Cadm4 WT allele, CGCAGTTCTGATCCAGCATC and AT CAGAGGACAGCTCATGAG;targeted,CGCA GTTCTGATCCAGCATC and GGCAGGAG GGTTGCCATGA. The generation of Cadm1 mutant mice was previously described (Fujita et al., 2005) .
RNA analysis. Total RNA was isolated from freshly dissected tissues using either TRI-reagent (Sigma-Aldrich) or RNeasy micro kit (QIA-GEN), cDNAs were obtained with SuperScript-II reverse transcriptase (Invitrogen) using oligo-dT. Specific PCR primer sets were designed according to mRNA sequences (GenBank database). PCR amplification product levels were normalized among samples with actin-specific primers. The following primer pairs were used for mRNAbased RT-PCR analysis: Cadm1 (exons 1-3), CA CTGATCCCCACAGGTGA and CAGCTGAC TGGTCACAGTGT; Cadm2 (exons 1-3), CGGT TCTCCGCTTCTACAG and CAGGACA GTGAGATAGGCC; Cadm3 (exons 1-5), CACT GATCCCCACAGGTGA and GAGCTGCTCA CAGTGAAGG; Cadm4 (exons 2-4), GACGGG ACAGGAAGTACAG and GTCCGAGAGCAAG CAGTG; Cadm4 (exons 3-6), CTCTGAAGGA CGAGCGATTC and GTTCCCTGTGACAGCA CAG; Cadm4 (exons 7-9), CAGAGACTCATT CCCACG and CGTGGGAATGAGTCTCTGC; actin GAGCACCCTGTGCTGCTCACCGAGG and GTGGTGGTGAAGCTGTAGCCACGCT.
Electrophysiology and motor function. Sciatic nerve conduction velocity measurements were performed on adult animals of each genotype (n Ͼ 5) essentially as described previously . Rotarod and tail suspension tests were performed as described previously (Novak et al., 2011) .
Antibodies. A purified rabbit antibody to Cadm4 was prepared by preabsorbing polyclonal rabbit anti-Cadm4 serum on a GST column, followed by a second preabsorption on GST-Cadm1. The following primary antibodies were used as well: mouse anti-Necl4ECD (NeuroMab), rat anti-MBP (Millipore Bioscience Research Reagents), rat and mouse antineurofilament (Millipore Bioscience Research Reagents), rabbit and mouse anti-Caspr , Chick anti-P0 (Aves), mouse anti-tubulin (Santa Cruz Biotechnology), mouse anti-MAG (EMD Millipore), mouse antibody to Kv1.2 (K14/16) (NeuroMab), rat anti-NrCAM (Lustig et al., 2001) , and mouse anti-pan sodium channels (Sigma-Aldrich). Fluorophore-coupled antibodies included the following: 488-coupled anti-rabbit was purchased from Invitrogen; Cy3-coupled antirabbit, Cy3-coupled anti-mouse, and Cy5-coupled anti-rat were obtained from Jackson ImmunoResearch Laboratories.
Immunolabeling and Western blot analysis. Sciatic nerves were teased and immunolabeled as previously described . For paraffin embedding, sciatic nerves were dissected, rinsed with PBS, and fixed for 48 h in Bouins buffer (Sigma-Aldrich). Tissues were then embedded in paraffin, sectioned, and mounted on glass slides. Antigen retrieval was done in boiling 0.01 M sodium citrate buffer (pH 6). Images were acquired using a Hamamatsu ORCA-ER CCD camera, controlled by Axiovision 4.7 acquisition software (Carl Zeiss). Processing of images was done using Photoshop CS3 software (Adobe). Quantification of the myelin segments was performed using Volocity 4.2.1 image analysis software (Improvision). For Western blot analysis, sciatic nerves were dissected, snap frozen in liquid nitrogen, and extracted in Laemmli sample buffer. Spinal cord samples were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1:100 protease inhibitor mixture, Sigma-Aldrich).
Electron microscopy. Sciatic nerves were fixed with Karnovsky fixative (2.5% glutaraldehyde, 4% PFA, 3% sucrose, in 0.1 M cacodylate buffer) and further processed as previously described Novak et al., 2011) . Samples were examined using a transmission electron microscope (CM-12; FEI) equipped with a camera (Eagle 2K°-2K; FEI). Semithin sections (1.5 m) were stained with toluidine blue and analyzed under a light microscope (Nikon Eclipse E800). Threedimensional reconstruction was prepared using focused ion beam/ scanning electron microscope (FIB/SEM) (dual-beam Helios 600 system-FEI).
Quantitation and statistical analysis. The number of normal and abnormal myelin profiles (see Fig. 2 ) was determined by counting Ͼ1200 fibers from 3 or 4 mice of each genotype (3-4 weeks of age). The percentage of myelin profiles at different developmental ages (see Fig. 4 ) was determined by counting Ͼ700 fibers from 3 mice of each genotype. Percentage of abnormal paranodes was calculated from 200 nodal regions in 3 mice (P60) of each genotype. In experiments in which multiple samples were compared, the statistical significance was determined using the two-tailed t test according to the Bonferroni correction. Myelinated axons g-ratio (myelin radius/myelinated axon radius) was calculated from Ͼ300 profiles in representative fields (mice 1-2 months of age; n ϭ 3 or 4).
Results

Cadm4 null and transgenic Cadm4dCT mice exhibit impaired motor function
To study the role of Cadm4 in myelination in vivo, we generated a conditional floxed allele of the gene that carries two loxP sites flanking exons 2-6 (Cadm4 fl/fl ; Fig. 1A ). Removal of these exons was achieved by crossing Cadm4 fl/fl mice with a PGK-Cre line (Lallemand et al., 1998) . Genotyping of PGK-Cre/Cadm4 fl/fl (referred to here as Cadm4 Ϫ/ Ϫ mice) was determined by Southern blot and PCR analysis of tail DNA (Fig. 1 B, C) . RT-PCR analysis performed on mRNA from sciatic nerves of control, heterozygous, and homozygous mutant mice using primers located within exons 3-6 showed a complete absence of Cadm4 transcript (Fig. 1D) . Similar analysis using primers located in exons 7-9 revealed that a truncated Cadm4 transcript was weakly present in the mutant (Fig. 1D) . Nevertheless, as revealed by Western blot analysis using two distinct antibodies directed against the cytoplasmic or the amino-terminal end of the protein, Cadm4 was completely absent in sciatic nerves of homozygous animals (Fig. 1E) . Similarly, no specific signal was detected by immunolabeling of sciatic nerve cross sections (Fig. 1F, top) , and teased fiber preparations, with an antibody to Cadm4 (Fig.  1F, bottom) , further indicating that Cadm4 Ϫ/ Ϫ is a complete null. As an additional approach to study the role Cadm4 plays in myelination, we generated transgenic mice expressing a myc-tagged deletion mutant of Cadm4 lacking its entire cytoplasmic domain (Cadm4dCT) under the MBP promoter (Farhadi et al., 2003) . Western blot analysis showed a strong expression of Cadm4dCT in Tg(mbpCadm4dCT ) mice but not in WT animals (Fig. 1G) . Blotting with an antibody directed to the cytoplasmic domain of Cadm4 (which only detects the endogenous protein) revealed that the expression of the transgene resulted in a decreased amount of the endogenous protein (Fig.  1G ). This conclusion was further supported by immunolabeling of transgenic sciatic nerve using antibodies to myc and Cadm4, showing a dramatic reduction in the expression of the endogenous Cadm4 in fibers expressing high levels of Cadm4dCT (Fig. 1H ) . Cadm4dCT was distributed along regions of noncompact myelin, where it was occasionally found in aggregates, alone or together with the endogenous Cadm4 (Fig. 1I ) .
Homozygous Cadm4 Ϫ/ Ϫ mice exhibited hind leg rigidity during their first 3 weeks of life. When suspended by their tail, they displayed spastic leg extension and an enhanced clasping reflex (Fig. 1J ). These abnormalities were more pronounced in Tg(mbp-Cadm4dCT ) mice, which also developed hindlimb paralysis (Fig. 1J ) . Cadm4 Ϫ/ Ϫ and Tg(mbp-Cadm4dCT ) mice tended to stagger and fell more rapidly from a rotarod compared with WT littermates, further indicating that either the absence of Cadm4, or its abnormal expression in Schwann cells, resulted in a motor coordination defect (Fig. 1K ). Akin to their motor deficits, both mutants exhibit a moderate but significant decrease in nerve conduction velocity (Fig. 1L ).
Cadm4
؊/؊ and Tg(mbp-Cadm4dCT) mice exhibit neuropathy-like focal hypermyelination Electron microscopy analysis of sciatic nerves isolated from adult Cadm4 Ϫ/ Ϫ and Tg(mbp-Cadm4dCT ) mice showed that these mutants formed myelin with thickness comparable with that of age-matched wild-type mice ( Fig. 2A-C ; average g-ratios: Cadm4 Ϫ/ Ϫ 0.61 Ϯ 0.02 vs 0.63 Ϯ 0.01 of littermate control; Tg(mbp-Cadm4dCT ) 0.68 Ϯ 0.03 vs 0.67 Ϯ 0.02 of littermate control). However, in contrast to WT nerves, myelinated axons in Cadm4 Ϫ/ Ϫ and Tg(mbp-Cadm4dCT ) displayed a range of myelin abnormalities, including tomacula (Fig. 2 E, F ) , commashaped myelin outfolds (Fig. 2G,I ), and redundant myelin profiles (Fig. 2 H, I, M, N ) . These abnormalities were more frequent in Tg(mbp-Cadm4dCT ) than in Cadm4 Ϫ/ Ϫ mutant mice. In some instances, the appearance of tomacula was accompanied with degeneration of the myelin around the axon (Fig. 2E) , and axonal displacement (Fig. 2F ) . The redundant myelin outfoldings were present within the Schwann cell cytoplasm, as well as between the myelin sheath and the axon (Fig. 2J ) . In longitudinal sections (Fig. 2L) , redundant myelin profiles were detected near paranodes and Schmidt-Lanterman incisures, in agreement with previous studies, suggesting that myelin outfolds originate from areas of noncompact myelin (Bolino et al., 2004; Bonneick et al., 2005; Tersar et al., 2007; Goebbels et al., 2012; Horn et al., 2012) . In 2-week-old transgenic mice, we also noted a detachment of the myelin sheath from the axon at the inner mesaxon, and the presence of multiple inner myelin lips, which reflect aberrant continuation of the myelination process ( Fig. 2O,P) . Quantitation of the number of myelin abnormalities using conventional transmission EM revealed that they ranged from 12.2% in Cadm4 Ϫ/ Ϫ to 22.4% in Tg(mbpCadm4dCT ) (Fig. 2D) . To further evaluate the extent of myelin abnormalities, we used serial section images of FIB/SEM (Knott et al., 2008) to follow individual axons (Fig. 3) . We either counted the number of myelin abnormalities in each section (abnormalities per field of view in Fig. 3C,D) , as a well as the number of different axons that show at least one myelin abnormality along their longitudinal axis (cumulative abnormalities; each affected axon was counted only once). As depicted in Figure 3D , we found that 81% of all myelinated axons of the Tg(mbpCadm4dCT) mutant will exhibit focal sites of hypermyelination at least once along their longitudinal axis. This result supports previous studies, suggesting that the number of myelin outfolds detected in cross sections of other tomacula neuropathy models represents an underestimate of the number of affected axons ( 
Absence of myelin abnormalities in mice lacking Cadm1, Cadm2, or Cadm3
The close sequence similarity between the four Cadm proteins , along with their overlapping expression (Kakunaga et al., 2005; Maurel et al., 2007; and their ability to interact heterophilically with each other Takai et al., 2008) , prompted us to examine whether other Cadm proteins play a role in PNS myelination. To this end, we used a gene-targeting approach to generate conditional floxed alleles of Cadm2 and Cadm3 by flanking their first coding exon with two loxP sites (Cadm2 fl/fl and Cadm3 fl/fl ; Fig.  4 A, B) (Fig. 4C,D) . In contrast to Cadm4 Ϫ/ Ϫ mice, homozygous Cadm2
Ϫ/ Ϫ animals (Fujita et al., 2005) showed no neurological abnormalities and were indistinguishable from their WT littermates. Immunolabeling of cross sections of sciatic nerves isolated from WT, Cadm1
mice, using antibodies to P0, neurofilament (NFH), and MBP, revealed the presence of normal myelin in all genotypes ( Fig.  4E-H ) . The analysis of semithin sections (Fig. 4E-H ) , as well of EM micrographs of sciatic nerve cross sections (Fig. 4I-L) , revealed that, in contrast to Cadm4 Ϫ/ Ϫ mutants, mice lacking Cadm1, Cadm2, or Cadm3 exhibit normal peripheral myelin. Furthermore, double-mutant mice lacking Cadm4 together with any other Cadm protein, exhibit myelin abnormalities that were comparable with those found in the single Cadm4 Ϫ/ Ϫ -null (Fig. 5) .
Cadm4
؊/؊ mice show a delay in the initiation of PNS myelination Developmental EM analysis of Cadm4 Ϫ/ Ϫ sciatic nerves revealed the appearance of abnormal myelin profiles already during the first postnatal week (Fig. 6) . At P1, most of the mutant Schwann cells had already sorted and established a 1:1 relationship with large axons as in WT nerves (Fig. 6 A, E), indicating that Cadm4 is not required for radial axonal sorting. However, in contrast to WT nerves, in which 35.4 Ϯ 8.4% of the Schwann cells already form a multilammelar myelin sheath around individual axons, myelin profiles were detected around only 13.8 Ϯ 1.8% of the axons in Cadm4 Ϫ/ Ϫ nerves at P1. At P3, myelination was detected in 43.2 Ϯ 2.1% of axons compared with 62.4 Ϯ 8.6% in WT. This significant difference between WT and Cadm4 Ϫ/ Ϫ mice was observed during the first postnatal days until P5, indicating a developmental delay (Fig. 6 B, C, F, G) . We note that myelin thickness in P3 and P5 mutant nerves was similar to wild-type animals (g-ratio: P3 WT 0.771 Ϯ 0.03, Cadm4 Ϫ/ Ϫ 0.774 Ϯ 0.018 and P5 WT 0.7287 Ϯ 0.03, Cadm4 Ϫ/ Ϫ 0.7280 Ϯ 0.004). These results indicate that Cadm4 is required to efficiently execute membrane wrapping, a notion that gains further support from previous findings demonstrating that addition of the extracellular domain of Cadm4 to myelinating cultures affected myelination but not Schwann cell ensheathment .
Absence of Cadm4 results in aberrant axon-glial contact and axonal organization
The expression and subcellular distribution of Cadm4 in Schwann cells are regulated by protein 4.1G (Ivanovic et al., 2012) and ␣II/␤II spectrin (Susuki et al., 2011) , suggesting that it may organize membrane contact sites by providing a direct link to the underlying cytoskeleton. In myelinating nerves, axon-glial contact sites organize the axolemma into distinct molecular domains. In WT nerves, Na ϩ channels are concentrated at the nodes of Ranvier and are separated from juxtaparanodal Kv1 channels by the paranodal junction (labeled for Caspr) (Fig.  7 A, C) . In addition, throughout the internode, Kv1 channels are located in a double strand flanking a single line of Caspr that apposes the inner mesaxon of the myelin sheath (termed juxtamesaxon) (Arroyo et al., 1999) . Immunofluorescence analysis of teased sciatic nerves from Cadm4 Ϫ/ Ϫ and Tg(mbpCadm4dCT ) mice revealed marked abnormalities in both genotypes (Fig. 7B-H ): (1) aberrant appearance of Caspr at the paranodes; (2) diffuse Caspr immunoreactivity away from the paranodes; (3) absence of Caspr and Kv1 channels from the juxtamesaxonal line; and (4) abnormal accumulation of Kv1 channels around the juxtaparanodes, as well as in patches along the internodes (occasionally flanked by Caspr). Quantitative analysis showed that 71 Ϯ 18% (250 sites, n ϭ 3) of the paranodes in Cadm4 Ϫ/ Ϫ displayed abnormal Caspr immunoreactivity, compared with7 Ϯ 2% (250 sites, n ϭ 3) in WT mice (Fig. 7I ). In agreement with these results, EM images of longitudinal sections of sciatic nerves isolated from Cadm4 Ϫ/ Ϫ (Fig. 7J ) and Tg(mbpCadm4dCT ) (Fig. 7) mice revealed abnormal splitting of the paranodal loops. These abnormalities were unique to Cadm4 Ϫ/ Ϫ and were not observed in mice lacking the other Cadm genes. To further ascertain that the effect Cadm4 has on the organization of myelinated axons is the result of its presence in Schwann cells, we eliminated its expression in these cells by crossing Cadm4 fl/fl mice with Desert Hedgehog (DHH)-Cre transgenic mice (DHH-Cre), in which Cre is active in Schwann cell precursor cells (Jaegle et al., 2003) . As shown in Figure 8A -C, both Cadm4 transcript and protein were undetectable in the sciatic nerve of DHH-Cre/ Cadm4 fl/fl mice. These mice also exhibit myelin abnormalities (i.e., tomacula, redundant myelin, and outfolds) comparable with the complete null ( Fig. 8D-H ) . Immunofluorescence analysis of teased sciatic nerves isolated from DHH-Cre/Cadm4 fl/fl mice showed severe Caspr abnormalities as in the complete nulls (Fig. 8I-K ) . Hence, the presence of Cadm4 in Schwann cells is essential for the establishment of accurate axon-glial contact sites and the functional organization of myelinated axons.
Discussion
Our data suggest that Cadm4 plays an essential role in the generation of functional myelinated nerves in the PNS by controlling myelin membrane growth, as well as by mediating an axon-glial contact necessary for the organization of the axolemma. We show that genetic deletion of Cadm4 or transgenic expression of a truncated Cadm4 in myelinating glia causes a CMT neuropathy-like phenotype characterized by focal hypermyelination (i.e., tomacula, outfolds, and redundant myelin) and disorganization of the axonal membrane. In addition, in young Tg(mbpCadm4dCT ) nerves, we also detected the presence of multiple inner lips, an abnormal configuration that may indicate that Cadm4 contributes to the formation of the inner mesaxon (i.e., the contact between the inner Schwann cell lip and the axon). In accordance, we found that, in the absence of Cadm4, Caspr and Kv1 channels disappears from the juxtamesaxonal line. A role for Cadm4 in mediating axon-glia contact is further supported by recent findings showing that ablation of MAG in CMT1A mice (i.e., C22 mice carrying seven copies of the human PMP22 gene) (Huxley et al., 1996) , in which Cadm4 expression is markedly reduced, resulted in detachment of the axon from the myelin sheath (Kinter et al., 2012) . The absence of Cadm4 in Schwann cells leads to abnormal organization of the underlying axonal membrane. Both Cadm4 Ϫ/ Ϫ and Tg(mbp-Cadm4dCT ) mutant mice exhibit abnormal distribution of Caspr and aberrant accumulation of Kv1 channels in patches near the juxtaparanodal region and along the internodes. We propose that the reorganization of the axolemma results from the abnormal formation of the mesaxon and the redistribution of Caspr and Kv1 channels from the mesaxonal line. Although yet to be investigated, it is likely that the function of Cadm4 in axonal organization is different from the one it plays in myelin membrane growth (see below). In support of this idea, it should be noted that similar axonal, but not myelin, abnormalities are also found in mice lacking protein 4.1G, which binds Cadm4 and regulates its expression at the axon-glial interface (Ivanovic et al., 2012) .
Cadm4 is thought to mediate axon-glia interaction by binding to axonal Cadm2 and Cadm3 (Maurel et al., 2007; ). Yet, we found that mice lacking Cadm1, Cadm2, or Cadm3 have normal PNS myelin, suggesting that, in contrast to Cadm4, they are dispensable for PNS myelination. This conclusion is further supported by the observation that double mutant mice lacking Cadm4, together with any other Cadm protein, exhibit myelin abnormalities that were comparable with those found in the single Cadm4-null. Although compensation by other Cadms in these animals cannot be excluded, these results raise the intriguing possibility that Cadm4 may exert its function by binding to other axonal ligands, or alternatively, by modulating other glia proteins. One potential candidate is erbB2, which is central for PNS myelination , and directly interacts with Cadm2 and Cadm4 (Kawano et al., 2009; Mizutani et al., 2011) . In addition, it was recently shown that neuregulin induces the association between Cadm1 and erbB4 in hypothalamic astrocytes, further providing a direct link between erbB receptors and Cadm proteins (Sandau et al., 2011) . Ϫ/ Ϫ mice (B,D), using antibodies to Caspr, Na ϩ channels (NaCh), and neurofilament (NFH; A,B); or to Caspr, Kv1.2, and NrCAM (C,D). Cadm4-null sciatic nerves show abnormal appearance of Caspr (compare insets in A and B), and Kv1 channel immunoreactivity was increased at the juxtaparanodes and adjacent area. Both Caspr and Kv1.2 channels are absent from the internodal double mesaxonal line (C, arrowheads). E, Labeling of teased sciatic nerves of the mutant with antibodies to Caspr and NaCh. The abnormal distribution of Caspr likely reflects unwinding of the paranodal loops. F, Labeling of Cadm4-null sciatic nerves fibers using antibodies to NaCh, Caspr, and Kv1.2. There is aberrant accumulation of Caspr (arrow) and Kv1 channels (arrowheads) away from the NaCh-containing node of Ranvier. G, Cadm4-null nerves exhibit focal accumulations of Kv1 channels along internodes (asterisks), which are occasionally flanked by Caspr immunoreactivity (arrowhead). Location of a node of Ranvier is indicated (n). H, Immunolabeling of teased sciatic nerves fibers of the Tg(mbp-Cadm4dCT ) mice show the same abnormalities as in null mice, including internodal accumulation of Kv1 channels (asterisks), and abnormal distribution of Caspr (an arrow in the middle panel marks the absence of Caspr from one side of the node). I, Percentage of nodal sites containing either normal or irregular Caspr immunoreactivity in WT and mutant (Cadm4 ) Furthermore, as myelination downstream of erbB2 is controlled by local phosphoinositide production Goebbels et al., 2012) , it is likely that regulation of Schwann cell membrane growth by Cadm4 is mediated through lipid signaling. In line with this hypothesis, we found that disruption of Cadm4 function results in focal hypermyelination reminiscent of the pathology observed in Charcot-Marie-Tooth neuropathies connected with phosphoinositide metabolism (Bolino et al., 2000; Houlden et al., 2001; Delague et al., 2007; . Two phosphoinositide signaling pathways that regulate Schwann cell myelination have recently emerged (Masaki, 2012; . The first is centered around myotubularin-related protein-2 (MTMR2), a phosphatase that dephosphorylates both PtdIns(3)P and PtdIns(3,5)P2 (Bolino et al., 2000; Houlden et al., 2001; Delague et al., 2007; . MTMR2 associates with Dlg1 (also known as SAP97), a scaffolding protein that in Schwann cells also interacts with the kinesin 13B (kif13B) motor and the exocyte protein Sec8 to regulate vesicular trafficking and local membrane homeostasis (Bolis et al., 2005 (Bolis et al., , 2009 ). In the absence of functional MTMR2, this homeostasis is disrupted, resulting in focal hypermyelination (Bolino et al., 2004; Bonneick et al., 2005) . The second pathway involves the interaction of Dlg1 with another lipid phosphatase, PTEN, which dephosphorylates (PtdIns3,4,5) and antagonizes the function of AKT/PI3K downstream of erbB2 (Pereira et al., 2012). During the first 2 weeks of myelination, Nrg1 type III stabilizes Dlg1 and PTEN complexes by reducing their ubiquitination and proteasomal degradation. This results in an increase in the expression of PTEN, which then negatively regulates myelination and modulating AKT phosphorylation . Accordingly, the absence of PTEN in myelinating Schwann cells results in focal hypermyelination and tomaculous neuropathy (Goebbels et al., 2012) . The focal abnormalities in myelination (in contrast to global enhancement of myelin thickness) detected in MTMR2, PTEN, as well as Cadm4 mutants, may be the result of the loss of the local negative regulation PTEN exerts in regions of noncompact myelin Goebbels et al., 2012) . Although further studies are required to reveal the exact mechanism by which Cadm4 modulates myelin membrane growth, one possibility is that it functions by localizing regulators of membrane homeostasis, such as Dlg1 and PTEN, to their subcellular site of action at the paranodal loops and the Schmidt-Lanterman incisures. In agreement, the abnormal growth of myelin in Cadm4 mutant mice appears to originate at these two subcellular regions of noncompacted myelin to which PTEN and Dlg1 localize (Ozcelik et al., 2010) .
Recent studies suggest that the polarized distribution of intracellular proteins in myelinating Schwann cells is a prerequisite for myelination (Masaki, 2012; for review, see Pereira et al., 2012) . In epithelial cells, such polarization is achieved through the recruitment of intracellular scaffolds to specific membrane contact sites by CAMs (Mellman and Nelson, 2008) . The cytoplasmic regions Fukuhara et al., 2003; Shingai et al., 2003; Kakunaga et al., 2005; Fujita et al., 2012) . Pals2/MPP6, also binds protein 4.1G, a cytoskeletal adapter protein that interacts with Cadm4 (Yang et al., 2011) , and is required for the localization of both Cadm4 and Pals2/MPP6 in myelinating Schwann cells (Ivanovic et al., 2012; Terada et al., 2012) . Although a direct interaction between Pals1 and Cadm4 is yet to be shown, the observation that Pals1 interacts with PATJ (Roh et al., 2002) may suggest the existence of a Cadm4-PATJ-Pals1 complex in myelinating Schwann cells. Notably, knockdown of Pals1 expression resulted in the formation of abnormal myelin infoldings, suggesting that it is required for local myelin membrane production (Ozcelik et al., 2010) , a process that is regulated by Dlg1 and PTEN Goebbels et al., 2012) . In addition, we note the possibility that Cadm4 could also be connected to the Par3-Par6-aPKC polarity complex, either directly or through PATJ and Pals1 (Plant et al., 2003; Wang et al., 2004) . This is of particular interest as it has been demonstrated that Par3 interacts with PTEN (von Stein et al., 2005; Wu et al., 2007; Feng et al., 2008) and targets it to specific membrane domains (Pinal et al., 2006; Feng et al., 2008) . Whereas in promyelinating Schwann cells Par3 resides at the axon-glial interface (Chan et al., 2006) , in myelinating Schwann cells it is found with Cadm4 at the Schmidt-Lanterman incisures and the paranodal loops Ozcelik et al., 2010) , where it may regulate local phosphoinositide signaling and actin dynamics (Song et al., 2012) . In accord, Schwann cell-specific deletion of Sirt2, which deacetylates Par3 (and hence activating aPKC), exhibits a transient delay in myelination and focal myelin protrusions as observed in Cadm4 mutants (Beirowski et al., 2011 ).
In conclusion, by generating mutant mice lacking each of the four Cadm proteins, as well as by expressing a truncated mutant form of Cadm4 in Schwann cells, we found that Cadm4, but not Cadm1, Cadm2, or Cadm3, is required for the proper establishment of myelinated nerves in the PNS. We show that Cadm4 mutant mice develop focal hypermyelination and myelin outfoldings reminiscent of the pathology observed when phosphoinositide metabolism is disrupted. Although further studies are required to clarify the molecular mechanism underlying the function of Cadm4 in myelinating Schwann cells, our results suggest that it may regulate actin cytoskeleton and membrane protrusions by affecting Schwann cell polarization and local phosphoinositide signaling.
